Autopsy report · NCT02148302
Clinical Trial to Evaluate Blister Graft Utilizing a Novel Harvesting Device for Treatment of Venous Leg Ulcers
Cause of deathFunding or business
“Stopped by sponsor. No interest in continuing trial due to business changes.”
Life of this trial
- Registered 4 months before it started.
- Ran for about 3 years 6 months before it stopped.
- 123 participants enrolled.
- Results were posted on the registry 2 years 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- SerenaGroup, Inc.
- Sponsor type
- University, hospital or other
- Conditions
- Impaired Wound Healing; Venous Insufficiency of Leg; Diabetic Ulcers
- Interventions
- Harvesting Device (CelluTome©)
- Participants
- 123
- Sites
- 18
- Countries
- United States
Trials that died the same way
- Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
“Trial terminated by Sponsor.” - Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)
“Sponsor decided to cancel this trial.” - A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients
“Trial was cancelled by Sponsor” - A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease
“Sponsor decision not to start trial” - A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy
“The sponsor decided not to conduct the expansion part of trial (part 2)”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.